Etienne Ruppé Selected Research

Etienne Ruppé Research Topics

9	Infections 01/2023 - 08/2010
2	Coinfection 01/2022 - 01/2021
2	Dysbiosis 01/2022 - 01/2020
2	Diarrhea 01/2018 - 08/2015
2	Urinary Tract Infections (Urinary Tract Infection) 03/2012 - 05/2009
1	Chronic Disease (Chronic Diseases) 10/2022
1	Critical Illness (Critically Ill) 10/2022
1	Bacterial Infections (Bacterial Infection) 09/2022
1	COVID-19 10/2021
1	Superinfection 10/2021
1	Peritonitis 01/2021
1	Brain Abscess (Abscess, Brain) 01/2021
1	Lemierre Syndrome 01/2021
1	Pleurisy (Pleuritis) 01/2021
1	Septic Shock (Toxic Shock Syndrome) 01/2020
1	Community-Acquired Infections 01/2020
1	Sepsis (Septicemia) 01/2020
1	Ventilator-Associated Pneumonia 01/2020
1	Healthcare-Associated Pneumonia 01/2016
1	Intraabdominal Infections 01/2016
1	Body Weight (Weight, Body) 03/2012

10	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2016
3	beta-Lactamases (beta-Lactamase)IBA 01/2020 - 05/2009
2	Carbapenems (Carbapenem Antibiotics)IBA 01/2022 - 03/2012
1	Colistin (Coly-Mycin)FDA Link 01/2023
1	Anti-Infective Agents (Microbicides)IBA 10/2022
1	beta-LactamsIBA 01/2022
1	Ribosomal DNA (rDNA)IBA 01/2022
1	salmochelinIBA 01/2020
1	aerobactinIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Virulence Factors (Pathogenicity Factors)IBA 01/2020
1	LactamsIBA 08/2015
1	Inosine Monophosphate (IMP)IBA 03/2012
1	Cefoxitin (Cefoxitin Sodium)FDA LinkGeneric 03/2012
1	CephamycinsIBA 03/2012

5	Therapeutics 10/2022 - 01/2016
1	Duration of Therapy 01/2020
1	Critical Care (Surgical Intensive Care) 01/2020